BIMZELX (bimekizumab-bkzx): Reviews and patient testimonials
Back to the list of medications
Medication indications
This medication contains a monoclonal antibody that targets and blocks interleukins 17A, 17F, and 17AF — proteins in the immune system that play a key role in inflammation associated with certain diseases, including psoriasis.
It is prescribed for the long-term treatment of:
- Moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy;
- Axial spondyloarthritis, including ankylosing spondylitis, in adults who have not responded adequately to other treatments;
- Psoriatic arthritis, used alone or together with methotrexate, when response to other disease-modifying treatments has been insufficient;
- Hidradenitis suppurativa (also called acne inversa)
Route of administration: Injectable
Molecule: bimekizumab-bkzx
It is prescribed for the long-term treatment of:
- Moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy;
- Axial spondyloarthritis, including ankylosing spondylitis, in adults who have not responded adequately to other treatments;
- Psoriatic arthritis, used alone or together with methotrexate, when response to other disease-modifying treatments has been insufficient;
- Hidradenitis suppurativa (also called acne inversa)
Route of administration: Injectable
Molecule: bimekizumab-bkzx
Patients' opinions on BIMZELX
Conditions related to this medication
Fact sheet
See the fact sheet
Fact sheet
See the fact sheet
Fact sheet
See the fact sheet
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.